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A BSTRA CT

The Effect of 5-Aminolevulinic Acid Based Photodynamic
Therapy and Photochemical Internalization of
Bleomycin on the F98 rat glioma cell line
by
K hishigzaya K harkhuu
Dr. Steen J. M adsen, Exam ination Com m ittee Chair
Chair, D epartm ent o f Health Physics
A ssociate Professor o f Health Physics
U niversity o f N evada, Las Vegas
The F98 rat gliom a cell line, a m odel for hum an m alignant glioma, was used to
investigate the efficacy o f 5-am inolevulinic acid (A LA )-m ediated photodynam ic therapy
(PDT) under varying light irradiation conditions. Cells in m onolayer w ere pre-incubated
in A LA for 4 hours prior to 635 nm light exposure. U sing clonogenic survival assays, it
was found that F98 glioma cells were sensitive to ALA-PDT; survival was inversely
proportional to light fluence. As evidenced from the LD 5 0 (4 J cm'^ at a fluence rate o f 35
m W cm'^), A LA -PD T was found to be m ore effective in F98 cells com pared to that found
in another com m only used rat gliom a cell line (BT 4 C). In contrast to findings in BT 4 C
cells, F98 survival was independent o f fluence rate.
A LA -PD T was tested for its ability to enhance the cytotoxicity o f Bleom ycin (BLM ),
a procedure term ed photochem ical internalization (PCI). F98 cells were incubated in
A LA and BLM prior to illumination. In all cases, no difference in survival was observed
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betw een F98 cells subjected to A LA -PCI delivery o f BLM and cells treated with
ALA-PDT. These findings suggest that ALA is not an ideal com pound for PCI
applications.
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C H A PTER 1

INTRO DU CTIO N
I . I G lioblastom a M ultiform e
G lioblastom a m ultiform e (GBM ) is a high grade gliom a and is one o f the m ost highly
m alignant, aggressive and difficult to treat tum ors. It is the m ost frequent prim ary brain
tum or in adults accounting for approxim ately I % o f all cancer deaths (M adsen and
Hirschberg 2006). The prognosis o f patients w ith these tum ors is poor, and traditional
therapies, such as surgical tum or resection follow ed by external beam radiation and/or
chem otherapy, have done little to alter the fatal outcome o f this disease. N o significant
advancem ents in the treatm ent o f GBM have occurred in the past three decades. A lthough
current therapies rem ain palliative, they have been shown to increase progression-free
survival. From the time o f diagnosis, the m ean survival time is approxim ately 17 w eeks
w ithout treatm ent (Rao 2003). M ean survival is inversely correlated w ith age. Patients
treated w ith optimal therapy, including surgical resection, radiation therapy, and
chem otherapy, have a m edian survival o f approxim ately 9 to 12 m onths, with 2-year
survival rates in the range o f only
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to 12% (Stupp et al. 2002). The 5-year survival rate

o f the disease has rem ained unchanged over the past 30 years, and stands at less than 5 %
(M cLendon and Halperin 2003).

GBM s present w ith an irregular, content enhancem ent pattern on Com puted
Tom ography (CT) and M agnetic Resonance Imaging (M RI) scans. They tend to have a
hem orrhagic com ponent and are characterized histologically by the presence o f vascular
endothelial proliferation and wide areas o f necrosis. Consistent with these areas o f
necrosis from astrocyte cell death, is significant disruption o f the b lood-brain barrier
(Rao 2003).
Treatm ent failure is due to the presence o f subpopulations o f highly invasive cells
that dissem inate into the surrounding brain parenchym a and result in tum or recurrence at
the edges o f the resection cavity and/or at distant sites in the brain (Loustau et al. 2004).
Surgery and radiotherapy are the m ainstay o f G B M treatments. Surgery is an
im portant first step in the treatm ent o f GBM . However, it is extrem ely difficult to remove
all tum or tissue w ithout causing severe dam age to norm al brain. Surgical studies have
concluded that com plete resection o f the tum or is observed in less than

2 0

% o f patients,

and is prim arily due to difficulties involving indistinct tum or boundaries (Stum m er et al.
2006). Conventional radiotherapy can prolong survival, but it cannot cure G B M - the
tolerance o f healthy brain being low er than the dose required for tum or control.
Chem otherapy is also not very effective, probably because m ost cytotoxic agents cannot
penetrate the blood-brain barrier in sufficient amounts. A ll-in-all, there is an urgent need
to find new therapies for this extrem ely aggressive disease. In particular, m uch effort has
been directed towards the developm ent o f localized therapies w ith the goal o f eradicating
infiltrating gliom a cells in the resection margin.

1.2 Photodynam ic Therapy
Photodynam ic therapy (PDT) is an em erging modality for the treatm ent o f neoplastic
and non-neoplastic diseases. It is a local form o f treatm ent that involves the
adm inistration o f a tum or-localizing photosensitizing drug follow ed by photoactivation.
This therapy results in a series o f photochem ical and photobiological events that cause
irreversible photo-dam age to tum or tissues. It is based on the concept that certain
photosensitizers preferentially accum ulate in tum or tissue follow ed by activation o f
appropriate w avelengths o f light to generate active m olecular species, such as free
radicals (especially singlet m olecular oxygen) that are toxic to cells.

Because o f the

tum or-specific photosensitizer accum ulation and the carefully directed light application,
PDT represents a more selective m ethod o f tum or treatm ent than chem o- or radiation
therapies.
The basic principles o f PDT are illustrated in Fig. 1. U pon absorption o f light, a
photosensitizer m olecule is excited to a short-lived singlet state. Follow ing excitation,
the sensitizer looses its energy by a variety o f com peting pathways. From the singlet state
the sensitizer can readily decay back to its ground state and em it energy in the form o f
fluorescence. A lternatively, it can convert, by intersystem crossing, to the m ore stable
triplet excited state. In this m etastable triplet state, the sensitizer can decay to its ground
state by em ission o f longer lived phosphorescence or, because o f its relatively long
lifetime (100 ps), it can interact w ith the local environm ent, i.e. tum or tissue, via a type I
and or type II reaction m echanism that initiates biochem ical reactions (O chsner 1997).

Singlet
excited
state
Triplet
excited
state

Fluoroscence
Phosphorosoem

P S Ground state

Fig. I. Photochem ical reactions o f the excited photosensitizer (PS)

Type I photochem istry involves direct electron transfer betw een the triplet sensitizer
and a nearby substrate to create radicals that further react w ith oxygen. This reaction w ill
result in peroxyl radicals which will undergo typical radical chain reactions (CalzavaraPinton 2007). Type II photochem istry involves energy transfer from the excited triplet
state o f the sensitizer to ground state m olecular oxygen resulting in the production o f
singlet oxygen - a highly reactive form o f oxygen. Singlet oxygen is a very pow erful
oxidizing agent that can oxidize many different biom olecules resulting in dam age to a
variety o f cellular structures. Due to its extremely short lifetim e (less than 0.04 ps in
biological tissue) and, accordingly, a short range o f action ( 1 0 - 2

0

nm) inside the cell, the

activity o f singlet oxygen is restricted to its point o f production m aking the photodam age
h ig h ly lo ca lized (D olm an s et al. 2003).

The photophysics o f PDT dictate that it is a light and oxygen catalyzed process w ith
no toxicity in the absence o f oxygen, and photosensitizing drugs are inactive until

illuminated. In summary, PDT efficacy depends on the availability o f photosensitizer,
light and oxygen.
The im portance o f tissue oxygenation in PDT has been dem onstrated by several
researchers (See et al. 1984; H enderson et al. 1987). The level o f tissue oxygenation m ust
be adequate to sustain singlet oxygen formation. Hypoxic cells, those w ith less than 5 %
oxygenation, have been found to be resistant to PDT (M acdonald and D ougherty 2001).
Henderson et al. (1987) have reported that oxygen consum ption depends on the fluence
rate o f light, and that tissue destruction m ight be enhanced by using low er fluence rates.
Low er fluence rates do not deplete the tissue’s oxygen supply as rapidly and, as a result,
the tissue is exposed to greater concentrations o f singlet oxygen for a longer time during
treatment.
W hile an am ple oxygen supply is necessary during PDT treatm ent, eventual
destruction o f the tum or m icrovasculature is also crucial to starve tum or cells o f oxygen
and nutrients since gliom as are know n to progress by inducing angiogenesis. Sitnik et al.
(1998) have suggested that fluence rates can be judiciously chosen to m axim ize exposure
to singlet oxygen during treatm ent, w hile the total fluence can be adjusted to ensure that
the tum or m icrovasculature eventually collapses, starving the tum or o f oxygen and
nutrients.
The optim al light fluence used to activate a photosensitizer in hum an cancers is
unknown. Light fluence is expressed in J cm'^, but the PDT dose depends on the
spectrum o f the light source, irradiation geometry, depth o f penetration, light scattering in
the tissue, concentration o f the photosensitizer in the tissue, hem orrhage w ithin the tumor.

am bient oxygen concentration and other factors. This m akes the PDT dose difficult to
calculate (W ebber et al. 2000).
The m ost com m only used photosensitizers for brain tum or therapy are Photofrin®
and hem atoporphyrin derivative. H owever, these sensitizers have the disadvantage o f
causing prolonged skin sensitization. Perhaps m ore im portantly, damage to norm al brain
tissue has been reported in preclinical studies (Ito et al. 2004). There are a num ber o f
second-generation photosenitizers and prodrugs under preclinical development. For
example, 5-am inolevulinic acid (ALA) has been successfully used to diagnose and treat
neoplastic tissue (Tsai et al. 2004). A LA itself is not a photosensitizer and serves as the
naturally occurring biological precursor for protoporphyrin IX (PpIX), a photosensitizer,
in hem e biosynthesis (Fig. 2). H eme synthesis is regulated by negative feedback control
on A LA production. W hen A LA is adm inistered exogenously, this inhibitory control can
be bypassed and enzym e ferrochelatase (an enzym e that incorporates iron into PpIX in
heme synthesis) activity becom es rate-lim iting enabling the accum ulation o f PpIX in
cells w hich renders them photosensitive (Solban et al. 2006).

CY TO PLASM

H e m e \.

glycine

-sj

Fe^+—

Succynil Co A

Protoporphyrin IX

-ALA
M ITO CHO N DRIO N
5-A LA

Porphobilinogen.

U roporphyrinogen
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Fig. 2. H em e biosynthetic pathway

A LA -induced PpIX has been shown to selectively accum ulate in a num ber o f
neoplastic tissues, w hich is probably due to altered activity levels o f the enzym es o f the
hem e biosynthetic pathw ay w ithin transform ed cells (Leunig et al. 2000). For exam ple,
uroporphyrinogen has been reported to be higher in some tum ors, w hereas ferrochelatase
is often low er (Peng et al. 1997). The preferential accum ulation o f A LA in tum ors has
obvious clinical relevance since it results in selective destruction o f neoplastic tissues.
N atural PpIX from A LA is form ed w ithin the m itochondria o f target cells.
M itochondria occupy 15-50% o f the total cytoplasm ic volum e o f m ost anim al cells, and
participate in more m etabolic functions than any other organelle (Chakrabarti et al. 1998):
their proper function is essential to m aintain norm al cellular metabolism. M itochondria
have been im plicated as an im portant target for PDT and their dam age has been shown to
directly correlate with cell death, in particular, apoptosis (D ougherty et al. 1998).
The fluorescence-guided resection o f glioblastom a m ultiform e by A LA -induced
PpIX has been investigated in a num ber o f clinical studies and the results suggest a role
for PDT as a therapeutic m odality (Stum m er et al. 2000). A LA -induced PpIX has several

light absorption maxim a, from the largest peak in the Soret band at about 405 nm, to
sm aller peaks in the Q-bands at approxim ately 510, 545, 580 and 630 nm. From a clinical
viewpoint, photosensitizers w ith absorption spectra in the 650 - 800 nm regions are
preferred since they allow deeper light penetration in tissue (C alzavara-Pinton et al.
2006).
A num ber o f studies exam ining the utility o f A LA in various brain tum or models
have been perform ed in the past several years (Friesen et al. 2002). The com bination o f
excellent tum or-to-norm al brain tissue localization (A ngell-Petersen et al. 2006; Lilge et
al. 1998) short period o f skin photosensitization (24-48 h) (K ennedy and Pettier 1992)
and the possibility o f oral adm inistration makes A LA a prom ising photosensitizer for use
in fractionated or repeated PDT treatm ents o f GBM patients.

1.3 Photochem ical Internalization
Photochem ical internalization (PCI) is a novel technology w hich m ay im prove the
therapeutic effect o f m acrom olecules and other com pounds that accum ulate in endocytic
vesicles (Berg et al. 2005). M olecules trapped in endocytic vesicles are inactive. PCI is
based on the photodynam ic effect w hich is used to rupture the vesicular m em branes o f
endosomes so that endocytosed intact m acrom olecules can be released into the cytosol
w here they may exert their therapeutic effects instead o f being degraded by lysosomal
hydrolases. The concept (illustrated in Fig. 3) is based on the use o f specially designed
photosensitizers, w hich localize preferentially in the m em branes o f endocytic vesicles.
Upon exposure to light o f appropriate w avelengths (usually red light), the photosensitizer
induces the form ation o f reactive oxygen species (e.g. singlet oxygen) w hich cause

photooxidation o f the endocytic m em branes and subsequent release o f encapsulated
m acromolecules. The PCI-based relocation and activation o f the m acrom olecules has the
advantage o f m inim al side effects since the effect is localized to the area exposed to light.
The endosom al escape o f m acrom olecules including genes, oligonucleotides and proteins
by means o f PCI has been docum ented both in vitro and in vivo and has been shown to
increase the therapeutic effect in a synergistic m anner (Berg et al. 2005).

Fig. 3. Transport o f m olecules to the cytosol by PCI. The photosensitizer (S) and the
selected m olecule (M ) are endocytosed by the cells (I, illustrates the invagination o f the
plasm a m em brane) and both com pounds end up in the same vesicles (II). W hen these
vesicles are exposed to light, the m em branes o f these vesicles will be ruptured and the
contents released (III) (Berg et al., 2005).

Photosensitizers used in PCI should fulfill certain criteria, perhaps m ost im portantly,
they should localize in the endocytic com partm ents (H ogset et al. 2003). A ccording to
Gaullier et al. (1995) PpIX was found to sublocalize to lysosom al com partm ents in
hum an kératinocytes after long term incubation (42h) w ith ALA. Thus, A LA -PD T m ay
have the potential to dam age endocytic vesicles releasing their contents under certain
conditions (Selbo et al. 2001). A LA -based PC I o f the im m unotoxin M O C 3I-gelonin has
been shown to cause significant cytotoxic effects in W iD r cells (a colon adenocarcinom a

cell line) (Selbo et al. 2001). This is an im portant observation and provides the rationale
for the proposed w ork in rat gliom a cell lines - the PCI effect has not been investigated in
brain tum or cell lines. O f particular interest is the ability o f A LA -based PCI to enhance
the effects o f chem otherapeutic agents such as bleom ycin (BLM ) for the treatm ent o f
m alignant gliomas. This is an im portant consideration since chem otherapeutic agents
have been relatively ineffective in the treatm ent o f brain tumors.

1.4 Bleom ycin
Bleom ycin (BLM ) is a w ater soluble glycopeptidic antibiotic used in anticancer
chem otherapy and is given as a treatm ent for several types o f cancers including headand-neck, m alignant lym phomas and testicular carcinomas. BLM possesses very high
intrinsic cytotoxicity and acts by causing D N A strand breaks. Indeed, as few as 500 BLM
m olecules introduced into the cytosol are sufficient to kill m any cell types (Pron et al.
1999). However, it is know n that the BLM effect is lim ited by its inability to cross the
plasm a m em brane due to its relatively large size (m olecular w eight o f 1.5 kDa) and
hydrophilic characteristic. The transport m echanism o f BLM into cells has been the focus
o f several studies. U sing radiolabeled BLM , Pron et al. (1993) found an association
betw een receptor proteins on the plasm a m em brane and the uptake o f BLM , suggesting it
is taken up by cells through a receptor-m ediated endocytotic m echanism . The observation
that BLM

appears incapable o f escaping from endocytic vesicles explains the

developm ent o f a variety o f techniques to perm eabilize the barrier m em brane, including
well know n electroporation techniques. U tilizing specifically localized photosensitizers
and light to rupture vesicle m em branes is a prom ising approach for exploiting the

10

therapeutic potential o f BLM . In vitro PCI studies w ith BLM have shown that
photochem ical treatm ent can substantially enhance the biological effect o f this agent in
W iD r colon adenocarcinom a and V79 lung fibroblast cell lines. (H ogset et al. 2003; Berg
et al. 2005).
BLM is know n as a cell cycle specific chem otherapeutic agent as it m ainly affects
dividing cells. The fact that healthy neurons and normal glial cells do not divide, or
possess extrem ely low division rates m akes BLM advantageous in clinical use o f brain
cancer therapy since cancer cells are characterized by its high cell division (L eif et al.
1993). The prim ary m otivation for using this chem otherapeutic agent is that it has been
used in a num ber o f PCI studies w hich can serve as benchm arks against w hich the results
o f the present w ork can be compared.

1.5 The F98 R at Gliom a Cell Line
The F98 rat gliom a cell line used in this study was originally established by D r s. A.
K oestner and W. W echsler at Ohio State University. It is chem ically induced in CDF
(Fischer) rats by the i.v. adm inistration o f a single dose o f N -ethyl-N -nitrosourea (ENU,
50mg kg

b.w.) on the 20* day o f gestation (Barth 1998). N itrosourea-induced

m alignant cell lines reliably produce rapidly growing tumors. The techniques involved
are relatively simple, cheap and in vitro, in vivo studies can be carried out in parallel
(W hittle et al. 1998). The biological characteristics o f this tum or closely resem ble those
o f hum an glioblastom a. The transplantable tum or displays an infiltrative pattern o f
growth w ithin the brain and is w eakly im m unogenic in syngeneic rats (Barth 1998).
K nowledge o f the im m unogenicity o f a tum or model is an im portant factor for
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determ ining its appropriateness in therapeutic studies w here survival is the end point. For
example, certain im m unogenic gliom a cell lines, like C6 and 9L are not suitable for
studies in im m unocom petent rats if the objective is to prolong and register anim al
survival (Fournier et al. 2003). F98 cells have been found to be resistant to a variety o f
treatm ent m odalities including chemo-, radio-, and im m unotherapy and, to this date, only
25% o f tum or-bearing animals have been cured using these standard therapeutic regim ens
(Barth et al. 2003). The failure o f cancer treatm ents for hum an gliom as is m ainly
attributed to its highly invasive nature. F98 cells are highly invasive and, as such, are
highly suitable for studying hum an gliom a resistance (Sibenaller et al. 2005).

1.6 Thesis Objectives
The overall objective o f this thesis is to determ ine the efficacy o f A LA -m ediated PDT
and PCI in an F98 rat gliom a cell line. The w ork consists o f three specific aims. ALA
dark toxicity and PpIX fluorescence yields will be investigated in specific aim #1. It is
hypothesized that A LA toxicity and PpIX fluorescence yields in F98 cells are sim ilar to
those observed in other rat gliom a cell lines.
In specific aim #2, the effects o f light fluence and fluence rate in the rat gliom a cell
line will be determined. There are num erous studies suggesting that low fluence rates
result in m ore dam age than high fluence rates for the same total fluence. It is very
im portant to elucidate the different fluence rate effects in photodynam ic therapy for
effective treatm ent planning. As has been found in other rat gliom a cell lines, it is
hypothesized that higher light fluences and low er fluence rates are m ore effective at
killing gliom a cells.
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In specific aim #3, the ability o f A LA -PCI to enhance the effects o f B LM in the F98
rat gliom a cell line will be investigated. It is hypothesized that A LA -PCI w ith BLM will
have a greater cytotoxic effect than that achievable with A LA -PD T or BLM alone.
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CH A PTER 2

M ATERIA LS AND M ETHODS
2.1 C hem icals
D ulbecco’s m odified Eagle m edium (D M EM ), Phosphate Buffered Saline (PBS), and
trypsin-ED TA w ere purchased from Invitrogen Corp., Carlsbad, CA. 5-A m inolaevulinic
acid (5-ALA) and bleom ycin in pow der form (15 lU per vial) w ere purchased from
Sigma (St.Louis, MO).

2.2 Cell Culture
The F98 cells used in all experim ents w ere provided by Dr. Chung-H o Sun from the
U niversity o f California, Irvine. O riginally, the F98 cell line was established from
gliomas induced in CDF (Fischer) rats by the i.v. adm inistration o f a single dose o f Nethyl-N-nitrosourea (ENU, 50 m g kg ' b.w .) on the 20* day o f gestation. Cells w ere
routinely cultured in m onolayer in D ulbecco’s m odified Eagle m edium (D M EM ),
supplem ented w ith 10% fetal bovine serum (FBS), 50 m M HEPES buffer (pH 7.4),
penicillin (100 U m f ') and streptom ycin (100 mg m f ') . They w ere incubated in a
hum idified cham ber w ith 5% C O 2 at 37°C. For routine m aintenance, cells were
subcultured at 80-90% confluence. Proliferating cells received fresh m edium every third
day. F98 cells w ere seeded in the m edium at a density o f about 150*10^ cells per 25 cm''
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cell culture flasks, and incubated for 48 hours prior to each experim ent. Prior to drug
treatment and irradiation, cells w ere sw itched to a serum-free m edium (0% FBS) since
serum can act as an extracellular com petitor for PpIX (Flanania et al. 1992).

2.3

PpIX Fluorescence

In one set o f experiments, F98 cells w ere incubated in A LA and a serum -free m edium
for 4 h. PpIX fluorescence intensity was evaluated for A LA concentrations ranging from
0 to 4 mM using a FACS C alibur cytometer. In another set o f experim ents, cells were
incubated in 1 mM A LA for times ranging from 1 to 24 h and PpIX fluorescence
intensity was evaluated using the cytometer.

2.4 ALA Toxicity
F98 cells were incubated in the dark for 4 h with 1 , 6 , 12, 18 or 24 m M A LA in a
serum-free medium. Exposure to light was avoided during incubation with ALA.
Following incubation, cells were harvested, counted and prepared for colony growth as
described in section 2.5.

2.5

Photodynam ic Therapy

F98 cells were seeded in the m edium at a density o f about 150 %10^ cells per 25 cm^
cell culture flasks. A fter 48 h, cells w ere w ashed with 5 ml PBS and 5 ml o f serum -free
DM EM was added. 100 mM A LA stock was prepared im m ediately before treatm ent w ith
100 mM HEPES buffer and pH adjusted to 7.3 - 7.6 using 10 M N aO H . 50 p i o f the 100
m M A LA stock was added to the cells in 5 ml serum -free m edium to a final
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concentration o f 1 m M and incubated for 4 h. The serum-free m edium (w ithout ALA)
was also used for the control group. Cells w ere assigned into three groups: group 1,
control - no ALA ; group 2, dark control - A LA only; and group 3, A LA -PD T. A fter
incubation, cells incubated with 1 m M A LA for 4 h (except the dark controls) were
subjected to light fluences o f 2, 4, 10 or 20 J cm ^ delivered at fluence rates o f 5, 25, or 40
m W cm ^. A ll illum inations w ere perform ed using a 400 pm core diam eter optical fiber
(with m icrolens) coupled to a diode laser (H igh Power D evices, N orth Brunsw ick, NJ)
em itting light at a w avelength o f 635 nm. Pow er output at the tip o f the fiber w as checked
w ith a pow er meter. The beam was expanded to a spot size o f 37.5 m m radius in order to
cover the m onolayer cell culture hom ogeneously. Im m ediately after irradiation, cells
w ere w ashed in PBS, harvested using trypsin, and resuspended in drug-free culture
medium. C ells w ere counted using a C oulter Counter and plated at various densities in
culture dishes and further incubated w ith the com plete m edium for colony form ation. All
experiments, in which cells were exposed to ALA, were carried out in subdued light. Cell
survivals w ere evaluated using a colony form ation assay. The clonogenic assay was
perform ed to assess the proliferation ability after ALA-PDT.

2.6

Bleom ycin Toxicity

BLM pow der w as dissolved in PBS and further diluted to achieve the desired
concentrations. F98 cells were incubated in varying concentrations (0.1 - 10 pg m f ') o f
BLM and serum -free m edium for 4 h. Following incubation, cells w ere w ashed,
trypsinized, counted and prepared for colony growth as described in section 2.5.
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2.7

A LA -Based PCI o f Bleomycin

F98 cells were subjected to varying incubation times in A LA and BLM prior to
illumination. In the initial set o f experiments, F98 cells w ere coincubated w ith 1 mM
ALA and 0.1 pg ml *BLM in serum -free m edium for 4 or 18 h. In later experim ents F98
cells w ere first incubated in ALA for 18 h follow ed by 4 h incubation in 0.1 pg m f ' BLM.
Following incubation, cells w ere irradiated w ith 635 nm light (fluence rate = 5 mW cm'^,
fluence = 2 J cm ^). Subsequent to inadiation, cells w ere harvested and prepared for
colony growth as described in section 2.5. In addition to the control (no ALA, no light),
two dark control groups (ALA only, 4 and 18 h) and a BLM + light group w ere evaluated.
All experim ents w ere carried out in subdued light.

2.8

Colony Form ation Assay

All F98 cultures w ere incubated in the dark for 7 - 9 days after the experim ents until
visible colonies were observed. Thereafter, cells were stained w ith crystal violet, and
surviving colonies counted m anually. Colonies containing m ore than 50 cells were
counted. The num ber o f colonies was expressed as a fraction o f the dark control (A LA
only).
Survival was determ ined by:
num ber o f colonies from treated cells/ num ber o f treated cells seeded

• X100

num ber o f colonies from dark control cells/ num ber o f dark control cells seeded

For all m easurem ents, triplicate plates were used for each point and each experim ent
was carried out more than three times. In all cases, data are presented as m ean ± SD.
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RESULTS
3.1

PpIX Fluorescence and ALA Toxicity

The data in Fig. 4 show that PpIX fluorescence in F98 cells increases as a function o f
ALA incubation time. After 18 h, the fluorescence signal reached a plateau suggesting
that the m axim um PpIX accum ulation had been attained in this cell line. A s illustrated in
Fig. 5, PpIX fluorescence reached a plateau at an ALA concentration o f approxim ately 2
mM. ALA toxicity was investigated by evaluating the survival o f F98 cells after
incubation for 4 h w ith increasing concentrations o f ALA (Fig. 6). A t concentrations up
to 12 m M no significant decrease in cell viability was observed. H owever, significant
dark toxicity w as seen in cells incubated at higher concentrations. Surviving fractions
markedly dim inished to about 24 % and 11 % at concentrations o f 18 and 24 m M
respectively.

18

Time (h)

Fig. 4. Time dependent PpIX fluorescence form ation in F98 cells. Cells w ere incubated in
1 mM A LA for different times. Each data point represents the m ean (±SE) o f 2
experim ental trials.
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Fig. 5. Dose dependent PpIX fluorescence form ation in F98 cells. Cells w ere incubated in
different concentrations o f ALA for 4 h. Each data point represents the m ean (±SE) o f 2
experim ental trials.
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!-

40

ALA concentration (mlVQ

Fig. 6. F98 cell survival as a function o f A LA concentration. In all cases, cells were
incubated in A LA and serum free m edium for 4 h. Each data point represents the m ean
(±SE) o f m ore than 3 experim ental trials.

3.2

Photodynam ic Effects on F98 Cells

Fig. 7 illustrates the survival o f F98 cells after 4 h incubation in 1 m M A LA and
exposure to 635 nm light delivered at a range o f fluences and fluence rates. In each case,
cellular viability was estim ated by norm alizing the results o f the colony form ation assay
to cells that were exposed to A LA -only (dark control). C ontrol experim ents were
perform ed to insure the reduction in cell viability during PD F was caused solely by
photosensitized P D F reactions. A fluence-dependent decrease in cell viability was clearly
observed at all three light fluence rates investigated. N either sole incubation w ith 1 m M
ALA, nor the laser light alone, had a significant effect on cell viability. Significant
reduction o f cell viability, relative to dark control, was observed when irradiating with 4,
10, or 20 J cm ^ at all fluence rates investigated. A t 2 J cm ^, however, low or no
significant phototoxicity was observed when com pared with dark control and the m ean
percent survivals were 95.7 ± 8.2%, 86.8 ± 12.1% and 94.4 ± 13.2% for fluence rates o f
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5, 25 and 40 m W cm'^ respectively. A t 4 J cm'^, the cell killing reached approxim ately
h alf the value o f non-irradiated controls (53.2 ± 8.3%, 49.3 ± 15.7%, and 42 ± 6.46% for
fluence rates o f 5, 25 and 40 m W cm ^ respectively). A fter exposure to 10 J cm ^ cell
survival decreased to 23.4 ± 4.9%, 18.8 ± 3.1% and 29.7 ± 9% for fluence rates o f 5, 25
and 40 m W cm ^ respectively. Exposures to 20 J cm"^ resulted in close to com plete cell
inactivation at all fluence rates investigated (5.7 ± 1.2%, 1.8 ± 0.3% and 6.4 ± 0.6% for
fluence rates o f 5, 25 and 40 m W cm'^ respectively). As illustrated in Fig. 7, there do not
appear to be significant differences in survival for the three fluence rates investigated.

□ 5 mW

t

N 25 mW

S

■ 40mW

>
I
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2 Je m
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20 Je m

Fig. 7. Fluence and fluence rate effect o f A LA -PD T in F98 cells. Cells w ere incubated
w ith 1 mM ALA for 4 h prior to treatment. Each data point represents the m ean (±SE) o f
m ore than 3 trials.

3.3 B le o m y c in T o x icity
The B LM dose response curve was generated for the F98 cell line following 4 h
treatm ent w ith increasing concentrations o f BLM (Fig. 8). Initial toxicity evaluation was
carried out for BLM concentrations ranging from 1 to 60 pg ml ’. For this range, colony

21

counts rapidly dim inished. A t concentrations above 10 pg ml ’ the toxicity w as so high
that the percent survival becam e negligible. The results presented in Fig. 8 show that F98
glioma cells are very sensitive to B L M - the L D 5 0 is approxim ately 0.25 pg ml ’.

BLM Concentration (iig/ml)

Fig. 8. F98 cell survival as a function o f BLM concentration. In all cases, cells were
incubated in BLM and serum free m edia for 4 h. Each data point represents the mean
(±SE) o f m ore than 3 experim ental trials.

3.4 Photochem ical Internalization
The effects o f A LA -PCI are illustrated in Figs. 9 and 10. In the case o f A LA and
BLM co-incubation (Fig. 9) the data show that there was no statistically significant
difference (95% confidence interval) in survival betw een cells subjected to PDT and
those treated w ith PCI for both incubation tim es investigated (4 and 18 h). N ot
surprisingly, PDT was m ore effective in the 18 hour A LA -incubated cells: 95 ± 8 % and
40 ± 7 % for PDT after 4 and 18 hour A LA incubation respectively. N o difference in
survival was observed betw een BLM -only cells and BLM -only cells exposed to light
suggesting that bleom ycin does not have a photosensitizing effect (data not shown). As
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illustrated in Fig. 10, changing the incubation conditions (18 h A LA followed by 4 h
BLM ) did not result in a statistically significant difference in survival betw een the PDT
and PCI groups.

120

CQ

14 hours
Xti

118 hours

I

I
ALA

BLM 0.1

PD T2J

PCI2J

Fig. 9. ALA based PCI o f BLM in F98 cells after 4 and 18 h co-incubation w ith
1 mM A LA and 0.1 pg ml ' B LM prior to light exposure (2 J cm'^). Each data point
represents the m ean (±SE) o f m ore than 3 trials.
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PDT 0.5J

PCI 0.5J

Fig. 10. A LA based PCI o f BLM in F98 cells after 18 h - 1 m M A LA follow ed by 4 h 0.1 pg ml * BLM incubation prior to light exposure (0.5 J cm ^). Each data point
represents the mean (±SE) o f 2 trials.
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DISCU SSION
A t present, glioblastom a m ultiform e is considered an incurable disease. Results have
been poor w ith conventional treatm ents involving surgery follow ed by adjuvant
radiotherapy and chem otherapy. Because o f the failure to control local recurrences with
conventional therapies, other m ethods are currently being developed (Sandem an 1986).
PDT is an appealing treatm ent option for GBM patients due to its selective ability to
target brain tum or cells. First generation photosensitizers, such as hem atoporphyrin
derivatives, are not ideally suited for PDT due to lack o f tum or selectivity and
com plications associated w ith cutaneous photosensitivity (D ougherty et al. 1990). Thus,
new photosensitizers and prodrugs (including ALA) are under active investigation to
evaluate their efficacy for PDT o f m alignant gliomas. A LA is a naturally occurring
m etabolite in the hem e synthetic pathw ay and a precursor o f PpIX, a potent
photosensitizer. A LA has been shown to have fewer side effects and a m uch more
transient phototoxicity com pared to first generation compounds (Rick et al. 1997).
In the present study, the utility o f A LA was assessed in the PDT treatm ent o f w eakly
im m unogenic F98 gliom a cells in vitro. Since some cells are not readily photosensitized
when exposed to exogenous A LA , it is advisable to perform in vitro studies in tum or cell
lines prior to the initiation o f anim al studies (Betz et al. 2002). W hetsell et al. (1978) and
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Percy et al. (1981) have shown that neurons, glial cells and Schwann cells in culture
synthesize porphyrins from ALA.
The results illustrated in Figs. 4 and 5 show that F98 gliom a cells are readily capable
o f synthesizing PpIX following A LA

exposure. The trend o f increasing PpIX

fluorescence intensity as a function o f A LA incubation tim e (Fig. 4) has also been
observed in other cell lines (G am arra et al. 2002) including the B T 4 C rat gliom a line
(Ziegler 2007). In F98 cells, a fluorescence plateau was reached after approxim ately 18 h
o f A LA incubation indicative o f feedback inhibition o f porphyrin synthesis (Stum m er et
al. 1998). The results illustrated in Fig. 5 show that PpIX fluorescence saturates at an
A LA concentration o f approxim ately 2 m M w hich is in good agreem ent w ith the findings
o f Ziegler (2007) in a B T 4 C rat gliom a cell line. The observation o f a plateau is o f
particular im portance, because it predicts that any given increase in A LA dose w ill not
inevitably increase the availability o f A LA -induced porphyrins. O n the other hand,
unw anted side-effects related to A LA may be m ore liable to occur if ALA doses in
patients are increased capriciously (Stum m er et al., 1998).
It has been shown that A LA can induce cytotoxicity in the absence o f light - the socalled dark toxicity which is due to the generation o f reactive oxygen species via A LA
oxidation (X ing et al. 2001). In the F98 cell line, a significant reduction in survival was
observed at A LA concentrations exceeding 12 m M (Fig. 6 ). B ased on this data, the L D 5 0
w ould appear to be in the range o f 12 to 18 mM . These results are in general agreem ent
with the findings in B T 4 C rat gliom a cells w here the L D 5 0 w as estim ated at 24 m M
(M adsen et al. 2006). The results are also consistent with the dark toxicity observed in a
W af hum an bladder carcinom a cell line w hich dem onstrated no decrease in survival at
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ALA concentrations less than 10 m M (Bachor et al. 1996). Thereafter, survival dropped
abruptly to 15 % at a concentration o f 15 mM.
Overall, the results presented in Figs. 4-6 provided guidance as to the optim al ALA
concentration and incubation tim e to use for the PDT and PC I experim ents. In all cases, a
1 mM A LA concentration and a 4 h incubation tim e were chosen for the PDT studies and
the initial PCI investigations.
The F98 gliom a cell line was used as a m odel system in this study since these cells
form rat brain tum ors that m im ic the fundam ental characteristics o f hum an GBM
including infiltrative growth and invasiveness. Furtherm ore, like hum an GBM s, F98derived tum ors have been show n to be refractory to a w ide variety o f treatm ent
modalities

including

standard

therapeutic

regim ens

consisting

o f radiation

and

chem otherapeutic agents (Barth et al. 2003).
Recently, m uch effort has been devoted to determ ining the optim al light dosim etry
param eters for PDT. To that end, the response o f F98 gliom a cells to various light
fluences and irradiation conditions w ere investigated. N ot surprisingly, a significant light
fluence dependent PDT response was observed as m easured by clonogenic survival:
higher light doses resulted in reduced survival. As illustrated in Fig. 7, exposure to light
doses o f 20 J cm ^ resulted in less than 10 % survival w hereas 2 J cm‘^ had little im pact
on cell viability. The results suggest that the F98 cell line is slightly m ore sensitive to
ALA -PD T com pared to B T 4 C cells. For exam ple, at a fluence rate o f 35 m W cm'^, the
LD50 for B T 4 C and F98 cells occurred at light fluences o f approxim ately 7 and 4 J cm ^,
respectively (M adsen et al. 2006). The reasons for this slight discrepancy in A LA -PD T
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response am ong the two gliom a eell lines are not know n but may be due to differenees in:
(1) cell metabolism , (2) photosensitizer binding, and/or (3) organelle concentration.
From the results presented in Fig. 9 it is hardly surprising that phototoxicity increased
significantly following 18 h incubation. For exam ple, a light fluence o f 2 J cm'^ resulted
in surviving fractions o f approxim ately 95 and 40 % following 4 and 18 h incubation,
respectively. The inereased PDT effieaey observed at longer ineubation times m ay be
attributed to a num ber o f faetors ineluding an inerease in cellular PpIX eoncentrations. In
addition, several investigators have deseribed the eritieal role o f intraeellular sensitizer
loealization and distribution in cellular phototoxicity and PDT efficacy. Longer exposure
to ALA m ay result in eom bined targeting o f several sites w ithin the cell due to PpIX
reloealization from m itoehondria to other organelles, including the plasm a m em brane
(Lye Yee et al. 2002). Sueh PpIX reloeation is also likely to eause a shift from an
apoptotic to a necrotic m ode o f cell death (M organ and O seroff 2001).
As illustrated in Fig. 7, there was no signifieant difference in F98 survival as a
function o f fluence rate. There have been numerous in vitro and in vivo studies
investigating the im paet o f fluence rate on PDT effieaey. In general, the deereased PDT
efficacy observed at high fluence rates is attributed to rapid oxygen depletion and there is
ample evidence to support this hypothesis in both m ultieellular 3-D spheroids (M adsen et
al. 2000) and animals (M oor et al. 1997). D uring exposure to high fluence rates, oxygen
depletion exeeeds replenishm ent and, as a result, the PDT effeet is lim ited only to eells in
close proxim ity to the oxygen supply, i.e., cells in the outer spheroid layers or tum or eells
in close proxim ity to the vasculature.
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Results o f fluence rate effects in m onolayers have been m ixed - some studies have
found a fluence rate dependence while others have failed to find such a relationship. The
lack o f a fluence rate effect is hardly surprising since all cells in m onolayers are w elloxygenated. In the present studies, it is hypothesized that oxygenation levels w ere
sufficient to ensure survival o f F98 cells under all fluence rates investigated. It is
interesting to note that, in a sim ilar study em ploying BT4C rat gliom a cells, a fluence rate
effect was observed (Ziegler 2007): higher fluence rates resulted in increased survival.
D ifferences in grow th conditions and cell m anipulation notw ithstanding, the reasons for
the discrepancy betw een the two cell lines is not understood at present and bears further
investigation.
The biological activity o f a num ber o f chem otherapeutic agents is lim ited by their
poor ability to enter the cytosol. BLM is a glycopeptidic antibiotic that binds to DNA
causing single and double strand breaks. This agent has been used in a num ber o f
standard cheom otherapeutic regim ens for the treatm ent o f head and neck, esophagus and
testicular carcinom as (Berg et al. 2005). U nfortunately, the clinical efficacy o f BLM is
limited due to drug resistance and dose-dependent induction o f pulm onary fibrosis (Jani
et al. 1992). Im provem ent in BLM efficacy w ould allow for the delivery o f low er doses
resulting in a concom itant decrease in morbidity.
B LM enters the cytosol through the endocytic pathway. Poor escape from endocytic
vesicles is a m ajor barrier for delivery o f the com pound since it is unable to reach the
cytosol w here it can be transported to the nucleus. Instead, BLM rem ains trapped in the
endocytic vesicles and finally degraded in lysosomes. Thus, the developm ent o f
endosom e-disruptive strategies, such as PCI, is o f great im portance since they may
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enhance the clinical efficacy o f BLM . The PCI technique, utilizing am phiphilic
photosensitizers to enhance the activity o f BLM , has been successfully docum ented by
Berg et al. (2005) on two different carcinom a cell lines. The central question addressed in
this study was w hether BLM efficacy could be enhanced by A LA -PC I in a rat gliom a cell
line. The results presented in Figs. 9 and 10 suggest that A LA -PCI was not an effective
delivery technique for the selected conditions investigated. In all cases, no significant
differences in survival w ere observed betw een cells exposed to PD T and those subjected
to PCI.
PCI efficacy is critically dependent on incubation time.

In Fig. 9 two incubation

times o f 4 and 18 h w ere considered based on the w ork o f Selbo et al. (2001) who
investigated A LA -PCI efficacy in the W iD r - colon adenocarcinom a cell line. These
investigators used fluorescence m icroscopy w hich show ed significant A LA -induced
PpIX translocation as a function o f incubation time. N ot surprisingly, at short incubation
times (a few hours), PpIX fluorescence was confined prim arily to the m itochondria. At
approxim ately 4 h, a small increase in PpIX fluorescence intensity was noted in the
plasm a m em brane. A t longer incubation times (> 24 h) a sharp increase in fluorescence
intensity was observed in the cytoplasm suggesting PpIX

localization to extra

m itochondrial sites and indicative o f an endosom e/lysosom e association. Taken together,
the fluorescence studies suggest that a PCI effect should be possible using a 4 h
incubation time and that the effect is optimal after 24 h.
In both cases considered in Fig. 9, cells w ere co-incubated in A LA and BLM . This
protocol can be problem atic if B LM -form ing vesicles detach from the plasm a m em brane
prior to sufficient incorporation o f PpIX. To m inim ize the risk o f this occurrence, a series
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o f experiments were perform ed in w hich F98 cells were first incubated in A LA for 18 h,
followed by 4 h BLM incubation. Unfortunately, the results illustrated in Fig. 10,
dem onstrate an absence o f the PCI effect under these incubation conditions. The lack o f
an observed PCI effect in the present w ork is likely due to lim itations associated w ith the
choice o f pro-drug (ALA). O ptim ization o f the PCI effect requires lipophilic sensitizers
that localize in the plasm a m em brane. In that context, A LA w ould appear to be a suboptimal choice since it is a hydrophilic m olecule and its associated photosensitizer (PpIX)
has strong m itochondrial affinity. It is also possible that the A LA -PpIX conversion
kinetics in the F98 gliom a cell line are different com pared to those in other cell lines such
as the W iD r line w here A LA -PCI has been show n to have some effect (Selbo et al. 2001).
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CO NCLUSIO N
PpIX fluorescence analysis in F98 rat gliom a cells yielded results consistent w ith
those observed in the B T 4 C rat gliom a cell line. D ata from the present study show ed that
m axim um PpIX fluorescence was achieved following 18 h A LA incubation. In addition,
it was found that the PpIX fluorescence intensity saturated at a relatively low ALA
concentration o f 2 mM . This has significant clinical im plications since it suggests that a
therapeutic effect can be achieved at A LA concentrations w ell tolerated by patients. ALA
dark toxicity w as found to be sim ilar to that observed in the B T 4 C cell line: the L D 5 0 was
estim ated to be betw een 12 and 18 m M in F98 gliom a cells.
The present study dem onstrated that A LA -PD T was very effective against F98
glioma cells. As expected, higher light fluences resulted in reduced survival. The results
suggest that the F98 cell line is m ore sensitive to A LA -PD T com pared to B T 4 C cells. The
L D 5 0 for F98 cells exposed to 35 m W cm'^ occurred at a light fluence o f approxim ately 4
J cm'^.
In contrast to the findings in B T 4 C cells, a fluence rate effect was not observed in the
F98 cell line. The reasons for this discrepancy are not understood and require further
investigation in more realistic oxygen-lim iting conditions such as those found in m ulticell
3-D spheroids and anim al tumors.
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A LA -PC I was not an effective enhancer o f bleom ycin efficacy in the F98 rat glioma
cell line. The lack o f an effect is likely due to the ineffectiveness o f A LA in PCI
applications. Future w ork w ill be aim ed towards a better understanding o f the PC I effect
using m ore appropriate am phiphilic photosensitizers that preferentially localize in plasm a
membranes.
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